Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
Shripad V. Bhagwat, Cecilia Mur, Matthew Vandekopple, Baohui Zhao et autres
In vivo single agent imlunestrant efficacy in ESR1-mutant and wild type xenograft and PDX breast cancer models.
Shripad V. Bhagwat, Cecilia Mur, Matthew Vandekopple, Baohui Zhao et autres
Imlunestrant, elacestrant, and fulvestrant mediated ER degradation, PGR gene inhibition and cell proliferation inhibition in T-47D parental and T-47D ESR1-Y537N cells.
Shripad V. Bhagwat, Cecilia Mur, Matthew Vandekopple, Baohui Zhao et autres
In vivo imlunestrant efficacy alone and in combination with abemaciclib, alpelisib, and everolimus in CDX breast cancer models.
Shripad V. Bhagwat, Cecilia Mur, Matthew Vandekopple, Baohui Zhao et autres
Statistical analysis of imlunestrant and fulvestrant efficacy alone and in combination with abemaciclib, alpelisib, and everolimus in ESR1-wild type and mutant xenograft and PDX breast cancer models
Shripad V. Bhagwat, Cecilia Mur, Matthew Vandekopple, Baohui Zhao et autres
Biochemical and in vitro characterization of imlunestrant.
Shripad V. Bhagwat, Cecilia Mur, Matthew Vandekopple, Baohui Zhao et autres
Statistical survival analysis and body weight change in MCF-7 intracranial model treated with imlunestrant or other SERDs.
Shripad V. Bhagwat, Cecilia Mur, Matthew Vandekopple, Baohui Zhao et autres
Imlunestrant PK/PD and uterotrophic activity.
Shripad V. Bhagwat, Cecilia Mur, Matthew Vandekopple, Baohui Zhao et autres
In vivo single agent imlunestrant efficacy in ESR1-mutant and wild type xenograft and PDX breast cancer models.
Shripad V. Bhagwat, Cecilia Mur, Matthew Vandekopple, Baohui Zhao et autres
Abstract Targeting of the estrogen receptor (ER) by antiestrogens is the standard of care for patients with ER+ HER2− advanced/metastatic breast cancer. Although antiestrogens that degrade ERα (fulvestrant) or block estrogen production (aromatase inhibitors) have improved patient outcomes, clinically important challenges remain …
Shripad V. Bhagwat, Cecilia Mur, Matthew Vandekopple, Baohui Zhao et autres
Statistical survival analysis and body weight change in MCF-7 intracranial model treated with imlunestrant or other SERDs.
Shripad V. Bhagwat, Cecilia Mur, Matthew Vandekopple, Baohui Zhao et autres
Biochemical and in vitro characterization of imlunestrant.
Shripad V. Bhagwat, Cecilia Mur, Matthew Vandekopple, Baohui Zhao et autres
In vivo imlunestrant efficacy alone and in combination with abemaciclib, alpelisib, and everolimus in CDX breast cancer models.
BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.
L'essentiel de l'actu tech du Burkina & d'Afrique, chaque semaine dans votre boîte mail.
Gratuit · sans spam · désinscription en un clic